---
figid: PMC7539288__41392_2020_311_Fig1_HTML
figlink: pmc/articles/PMC7539288/figure/Fig1/
number: F1
caption: 'Overview of the NAD+ metabolism and its physiological function. Mammalian
  cells can synthesize NAD+ de novo from tryptophan by the kynurenine pathway or from
  NA by the Preiss‐Handler pathway, while most NAD+ is recycled via salvage pathways
  from nicotinamide (NAM), a by-production of NAD+-consuming reactions. NAD+ can be
  reduced into NADH in the metabolic processes, including glycolysis, fatty acid oxidation
  and the TCA cycle. NADH, in turn, drives the generation of ATP via OXPHOS, the production
  of lactic acid from pyruvate, and the desaturation of PUFAs. NADPH plays an essential
  role in antioxidant defense and regulates cellular signaling via NADPH oxidases
  (NOXs). Moreover, NAD+ is found to decorate various RNAs in different organisms
  as nucleotide analog and serves as an alternative adenylation donor for DNA ligation
  in NHEJ repair. NAD+ also acts as a co-substrate for a wide variety of enzymes,
  including PARPs, sirtuins, CD38/CD157 and SARM1, impacting metabolism, genomic stability,
  gene expression, inflammation, circadian rhythm and stress resistance. Using NAD+
  as a co-substrate, both PARPs and sirtuins regulate their target molecules, generating
  NAM as a by-product. The CD38/CD157 and SARM1 also catalyze NAD+ to NAM, producing
  ADPR and cADPR. Abbreviations: IDOs, indoleamine 2,3-dioxygenase; QA, quinolinic
  acid; NAMN, nicotinate mononucleotide; QPRT, quinolinate phosphoribosyl-transferase;
  NAPRT, nicotinic acid phosphoribosyltransferase; NMNATs, nicotinamide mononucleotide
  adenylyl transferases; NADSYN, NAD synthase; NR, nicotinamide riboside; Trp, tryptophan;
  NADKs, NAD+ kinases; PARPs, poly (ADP-ribose) polymerases; NNT, nicotinamide nucleotide
  transhydrogenase; TDO, tryptophan 2,3-dioxygenase; SARM1, sterile alpha and TIR
  motif containing 1; NNMT, Nicotinamide N-methyltransferase; NMN, nicotinamide mononucleotide;
  PUFAs, polyunsaturated fatty acids; NAM, nicotinamide'
pmcid: PMC7539288
papertitle: 'NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.'
reftext: Na Xie, et al. Signal Transduct Target Ther. 2020;5:227.
pmc_ranked_result_index: '34398'
pathway_score: 0.9527899
filename: 41392_2020_311_Fig1_HTML.jpg
figtitle: NAD+ metabolism and its physiological function
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7539288__41392_2020_311_Fig1_HTML.html
  '@type': Dataset
  description: 'Overview of the NAD+ metabolism and its physiological function. Mammalian
    cells can synthesize NAD+ de novo from tryptophan by the kynurenine pathway or
    from NA by the Preiss‐Handler pathway, while most NAD+ is recycled via salvage
    pathways from nicotinamide (NAM), a by-production of NAD+-consuming reactions.
    NAD+ can be reduced into NADH in the metabolic processes, including glycolysis,
    fatty acid oxidation and the TCA cycle. NADH, in turn, drives the generation of
    ATP via OXPHOS, the production of lactic acid from pyruvate, and the desaturation
    of PUFAs. NADPH plays an essential role in antioxidant defense and regulates cellular
    signaling via NADPH oxidases (NOXs). Moreover, NAD+ is found to decorate various
    RNAs in different organisms as nucleotide analog and serves as an alternative
    adenylation donor for DNA ligation in NHEJ repair. NAD+ also acts as a co-substrate
    for a wide variety of enzymes, including PARPs, sirtuins, CD38/CD157 and SARM1,
    impacting metabolism, genomic stability, gene expression, inflammation, circadian
    rhythm and stress resistance. Using NAD+ as a co-substrate, both PARPs and sirtuins
    regulate their target molecules, generating NAM as a by-product. The CD38/CD157
    and SARM1 also catalyze NAD+ to NAM, producing ADPR and cADPR. Abbreviations:
    IDOs, indoleamine 2,3-dioxygenase; QA, quinolinic acid; NAMN, nicotinate mononucleotide;
    QPRT, quinolinate phosphoribosyl-transferase; NAPRT, nicotinic acid phosphoribosyltransferase;
    NMNATs, nicotinamide mononucleotide adenylyl transferases; NADSYN, NAD synthase;
    NR, nicotinamide riboside; Trp, tryptophan; NADKs, NAD+ kinases; PARPs, poly (ADP-ribose)
    polymerases; NNT, nicotinamide nucleotide transhydrogenase; TDO, tryptophan 2,3-dioxygenase;
    SARM1, sterile alpha and TIR motif containing 1; NNMT, Nicotinamide N-methyltransferase;
    NMN, nicotinamide mononucleotide; PUFAs, polyunsaturated fatty acids; NAM, nicotinamide'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACMSD
  - TYRP1
  - TDO2
  - IDO1
  - QPRT
  - NNT
  - NAPRT
  - NT5E
  - NAMPT
  - CD38
  - ACSM3
  - NNMT
  - BST1
  - SARM1
  - ADCY2
  - ADCY3
  - ADCY5
  - ADCY6
  - ADCY8
  - ADCY9
  - ADCY10
  - ADCY4
  - ADCY1
  - ADCY7
  - NAD
  - Picolinic acid
  - Kynurenine
  - NADPH
  - NADP
  - Quinolinic
  - Tryptophan
  - Trp
  - Pentose phosphate
  - Lactic acid
  - PUFA
  - NADKS
  - NAMN
  - Nicotinic acid
  - NADSYN
  - NADH
  - NAAD
  - Fatty acid
  - Tricarboxylic acid
  - NAMPT
  - Nucleotide
  - Ac
  - SAH
genes:
- word: ACMSD
  symbol: ACMSD
  source: hgnc_symbol
  hgnc_symbol: ACMSD
  entrez: '130013'
- word: (Trp)
  symbol: TRP
  source: hgnc_alias_symbol
  hgnc_symbol: TYRP1
  entrez: '7306'
- word: TDO
  symbol: TDO
  source: hgnc_alias_symbol
  hgnc_symbol: TDO2
  entrez: '6999'
- word: IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: QPRT
  symbol: QPRT
  source: hgnc_symbol
  hgnc_symbol: QPRT
  entrez: '23475'
- word: NNT
  symbol: NNT
  source: hgnc_symbol
  hgnc_symbol: NNT
  entrez: '23530'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: CD73
  symbol: CD73
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: CD38
  symbol: CD38
  source: hgnc_symbol
  hgnc_symbol: CD38
  entrez: '952'
- word: SAH
  symbol: SAH
  source: hgnc_prev_symbol
  hgnc_symbol: ACSM3
  entrez: '6296'
- word: NNMT
  symbol: NNMT
  source: hgnc_symbol
  hgnc_symbol: NNMT
  entrez: '4837'
- word: CD157
  symbol: CD157
  source: hgnc_alias_symbol
  hgnc_symbol: BST1
  entrez: '683'
- word: SARM1
  symbol: SARM1
  source: hgnc_symbol
  hgnc_symbol: SARM1
  entrez: '23098'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
chemicals:
- word: NAD
  source: MESH
  identifier: D009243
- word: Picolinic acid
  source: MESH
  identifier: C030614
- word: Kynurenine
  source: MESH
  identifier: C029366
- word: NADPH
  source: MESH
  identifier: D009249
- word: NADP
  source: MESH
  identifier: D009249
- word: Quinolinic
  source: MESH
  identifier: D017378
- word: Tryptophan
  source: ''
  identifier: ''
- word: Trp
  source: MESH
  identifier: C509690
- word: Pentose phosphate
  source: MESH
  identifier: D010429
- word: Lactic acid
  source: MESH
  identifier: D019344
- word: PUFA
  source: MESH
  identifier: D015525
- word: NADKS
  source: ''
  identifier: ''
- word: NAMN
  source: ''
  identifier: ''
- word: Nicotinic acid
  source: MESH
  identifier: D009539
- word: NADSYN
  source: ''
  identifier: ''
- word: NADH
  source: MESH
  identifier: D009243
- word: NAAD
  source: MESH
  identifier: C053851
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: Tricarboxylic acid
  source: MESH
  identifier: D014233
- word: NAMPT
  source: MESH
  identifier: C085455
- word: Nucleotide
  source: MESH
  identifier: D009711
- word: Ac
  source: MESH
  identifier: D000186
diseases:
- word: SAH
  source: MESH
  identifier: D013345
figid_alias: PMC7539288__F1
redirect_from: /figures/PMC7539288__F1
figtype: Figure
---
